1. Home
  2. MRVI vs FPH Comparison

MRVI vs FPH Comparison

Compare MRVI & FPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • FPH
  • Stock Information
  • Founded
  • MRVI 2014
  • FPH 2009
  • Country
  • MRVI United States
  • FPH United States
  • Employees
  • MRVI N/A
  • FPH N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • FPH Real Estate
  • Sector
  • MRVI Health Care
  • FPH Finance
  • Exchange
  • MRVI Nasdaq
  • FPH Nasdaq
  • Market Cap
  • MRVI 312.4M
  • FPH 340.3M
  • IPO Year
  • MRVI 2020
  • FPH 2017
  • Fundamental
  • Price
  • MRVI $2.22
  • FPH $5.45
  • Analyst Decision
  • MRVI Hold
  • FPH
  • Analyst Count
  • MRVI 10
  • FPH 0
  • Target Price
  • MRVI $6.84
  • FPH N/A
  • AVG Volume (30 Days)
  • MRVI 1.9M
  • FPH 127.6K
  • Earning Date
  • MRVI 05-12-2025
  • FPH 07-17-2025
  • Dividend Yield
  • MRVI N/A
  • FPH N/A
  • EPS Growth
  • MRVI N/A
  • FPH 69.50
  • EPS
  • MRVI N/A
  • FPH 1.24
  • Revenue
  • MRVI $241,856,000.00
  • FPH $241,148,000.00
  • Revenue This Year
  • MRVI N/A
  • FPH N/A
  • Revenue Next Year
  • MRVI $10.73
  • FPH N/A
  • P/E Ratio
  • MRVI N/A
  • FPH $4.37
  • Revenue Growth
  • MRVI N/A
  • FPH 11.66
  • 52 Week Low
  • MRVI $1.67
  • FPH $2.88
  • 52 Week High
  • MRVI $10.03
  • FPH $6.71
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 52.01
  • FPH 51.01
  • Support Level
  • MRVI $2.20
  • FPH $5.36
  • Resistance Level
  • MRVI $2.41
  • FPH $5.64
  • Average True Range (ATR)
  • MRVI 0.15
  • FPH 0.18
  • MACD
  • MRVI 0.01
  • FPH -0.02
  • Stochastic Oscillator
  • MRVI 58.06
  • FPH 18.87

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

Share on Social Networks: